| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/09/2008 | WO2008027912A3 Prediction of an agent's or agents' activity across different cells and tissue types |
| 10/09/2008 | WO2008022019A3 Promiscuous her-2/neu cd4 t cell epitopes |
| 10/09/2008 | WO2008019131A3 Methods and compositions for treating ige-mediated diseases |
| 10/09/2008 | WO2008011567A3 Cell systems and methods for detecting proliferation activity |
| 10/09/2008 | WO2008008708A3 Lung cancer diagnostic assay |
| 10/09/2008 | WO2008003053A3 Minimizing effects of dye crosstalk |
| 10/09/2008 | WO2007143206A3 Compositions and methods for removal of dna from a sample |
| 10/09/2008 | WO2007140388A3 Ablation based laser machining of biomolecule patterns on substrates |
| 10/09/2008 | WO2007123967A3 Biosensors and methods for detecting agents |
| 10/09/2008 | WO2007120252A3 Soluble human m-csf receptor and uses thereof |
| 10/09/2008 | WO2007115207A3 Irf-5 haplotypes in systemic lupus erythematosus |
| 10/09/2008 | WO2007104062A8 Compositions and methods based on peptide binding profiling |
| 10/09/2008 | WO2007098037A3 Sequential reporter enzyme luminescence (srl) methods and compositions for practicing the same |
| 10/09/2008 | WO2007095729A8 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 10/09/2008 | WO2007089367A3 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer |
| 10/09/2008 | WO2007087289A3 Anti-fcrn antibodies for treatement of auto/allo immune conditions |
| 10/09/2008 | WO2007084740A3 Tat-030 and methods of assessing and treating cancer |
| 10/09/2008 | WO2007081902A3 Method and apparatus for high throughput diagnosis of diseased cells with microchannel devices |
| 10/09/2008 | WO2007005867A3 Compositions and methods for providing a graded response in a protein |
| 10/09/2008 | WO2006108051A3 Compositions and methods relating to alzheimer's disease |
| 10/09/2008 | WO2005098396A3 High-density ion transport measurement biochip devices and methods |
| 10/09/2008 | US20080249894 Product samples, methods for producing product samples and methods for distribution of product samples |
| 10/09/2008 | US20080249738 Method of determining a dimension of a sample of a construction material and associated apparatus |
| 10/09/2008 | US20080249715 Method for identifying markers |
| 10/09/2008 | US20080249606 Methods for Determining the Effect of a Treatment on the Cross-Beta Structure Content of a Protein; Selection of Treatments and Uses Thereof |
| 10/09/2008 | US20080249554 Method and apparatus for penetrating tissue |
| 10/09/2008 | US20080249293 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 10/09/2008 | US20080249174 A transgenic knockout animal whose genome comprises a heterozygous disruption of at least one endogenous gene, Sptlc1 and/or Sptlc2, encoding a serine palmitoyl-CoA transferase (SPT) subunit;screening SPT enzyme inhibitors for a ligand/protein binding Sptlc1 and/or Sptlc2; myriocin, antiatherosclerois |
| 10/09/2008 | US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder |
| 10/09/2008 | US20080249081 Compounds for the treatment of pain and screening methods therefor |
| 10/09/2008 | US20080249056 agents that affect the activity and/or expression of CXCL16 can be used to alter the uptake of D-type CpG oligodeoxynucleotides; to decrease an immune response; antagonist of ADAM-10 is GW280264X, G1254023X or GM6001 |
| 10/09/2008 | US20080249054 using a PAT family protein to screen agents for the ability to regulate lipid metabolism; obesity, diabetes [non-insulin and insulin dependent], hypertension, coronary artery disease, hyperlipidemia, hypolipidemia, lipid metabolism disorders, lipid deposition disorders, lipodystrophies |
| 10/09/2008 | US20080249053 Compositions And Methods For Detecting And Treating Neurological Conditions |
| 10/09/2008 | US20080249050 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 10/09/2008 | US20080249045 MGAL: A GAL Gene Switch-Based Suite of Methods for Protein Analyses and Protein Expression in Multicellular Organisms and Cells Therefrom |
| 10/09/2008 | US20080249042 cultured prokaryotic or eukaryotic cell transformed or transfected with expression construct; vectors; treating retinal disease or blindness |
| 10/09/2008 | US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis |
| 10/09/2008 | US20080249025 Peptide fragments of p21; antiproliferative agents |
| 10/09/2008 | US20080249012 INCREASING LIFE SPAN BY MODULATION OF Smek |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080249004 Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity |
| 10/09/2008 | US20080248997 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners |
| 10/09/2008 | US20080248996 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 10/09/2008 | US20080248995 Contact candidate compound with transfected expression vector containing heterologous gene linked to PPAR promoter and expression vector encoding FOXO1 protein; compare level of expression with absence of candidate to identify promoter |
| 10/09/2008 | US20080248972 Laminating a protein non-adsorptive substance with a negative charge on a substrate surface with a positive charge; modifying the protein non-adsorptive surface into a protein adsorptive surface; and adsorbing a protein in the locally modified region |
| 10/09/2008 | US20080248971 Method for providing microarrays |
| 10/09/2008 | US20080248969 Dividing the nucleotide sequence of each member of the group into subsequences, where two of the subsequences overlap; generating probe sets capable of assigning alleles at HLA or KIR loci |
| 10/09/2008 | US20080248966 Applying an analyte or biological particles to an exposing domain; passing electromagnetic signals from the sample to the exterior, allowing detection of at least 50 particles,exposing, onto an array of active detection elements, one-dimensional spatial representation of electromagnetic signals |
| 10/09/2008 | US20080248965 Method and a system for determination of particles in a liquid sample |
| 10/09/2008 | US20080248964 Method and a system for determination of particles in a liquid sample |
| 10/09/2008 | US20080248963 Hybridization Method |
| 10/09/2008 | US20080248953 Applying purified polypeptide that is a bacteriocin and possesses plant growth and/or disease resistance promoting activity to a plant or plant seed |
| 10/09/2008 | US20080248594 Organic non-sugar compounds for protection of biologically active molecules and conjugate labels and methods of use thereof |
| 10/09/2008 | US20080248593 Method for detection of fluoride or hydrogen fluoride and detection kit |
| 10/09/2008 | US20080248592 Thin-film comprising nucleic acid conjugated colloids and electron transfer moiety for use in replication of preferential nucleotide sequences |
| 10/09/2008 | US20080248591 Electrode-free apparatus for detection or quantification of an analyte in a sample |
| 10/09/2008 | US20080248590 Integrated lab-on-a-chip for detection of preferential bioparticles in solution |
| 10/09/2008 | US20080248589 Sample Presentation Device |
| 10/09/2008 | US20080248588 Shrimp allergen, anti-shrimp allergen antibody, and use thereof |
| 10/09/2008 | US20080248585 Protein/Peptide Sequencing By Chemical Degradation in the Gas Phase |
| 10/09/2008 | US20080248584 Trityl derivatives for enhancing mass spectrometry |
| 10/09/2008 | US20080248582 Using multicompartment apparatus comprising flexible walls to separate and monitor concentration of leukocytes, lymphocytes and stem cell in mixture |
| 10/09/2008 | US20080248581 Using hemacrit inteference as evaluative tool in accuractely determining blood glucose concentrations; bioassay calibration |
| 10/09/2008 | US20080248580 Method for Determining the Endogenous Antioxidative Potential of Beverages by Means of Esr Spectroscopy |
| 10/09/2008 | US20080248579 Method of stabilizing human natriuretic peptides |
| 10/09/2008 | US20080248578 Detection of explosives and other species |
| 10/09/2008 | US20080248566 Matriptase, a serine protease and its applications |
| 10/09/2008 | US20080248528 Erythrovirus and its applications |
| 10/09/2008 | US20080248516 Using cells which over express g-protein coupled receptors as drug screening tools; high throughput and signal transduction assays |
| 10/09/2008 | US20080248515 Optimizing culture medium for CD34<+> hematopoietic cell expansion |
| 10/09/2008 | US20080248510 Immunoglobulin receptor for use as evaualtive tool in measuring strength of receptor ligand affinity |
| 10/09/2008 | US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity |
| 10/09/2008 | US20080248508 Dissolving chitosan in heated hydroxide base with constant stirring, neutralize, expose to endotoxin free water from slurry, transfer to closed system, use immunoglobulin to confirm chitosan slurry is pyrogen free |
| 10/09/2008 | US20080248507 C-erbB-2 external domain: GP75 |
| 10/09/2008 | US20080248506 Method of Monitoring Anti-Tumor Activity of an Hdac Inhibitor |
| 10/09/2008 | US20080248505 Detection of Lipid Oxidising Abzymes in Samples |
| 10/09/2008 | US20080248504 Agglutination Assay |
| 10/09/2008 | US20080248503 Methods of Screening Compounds to Predict Toxicity and Residual Proliferative and Differentiation Capacity of the Lympho-Hematopoietic System |
| 10/09/2008 | US20080248502 Using coxsackie virus and adenovirus receptor (CAR) specific immunoglobulin for treatment and prevention of contact dermatitis |
| 10/09/2008 | US20080248501 Methods of Diagnosing Ovarian Cancer and Kits Therefor |
| 10/09/2008 | US20080248500 Apolipoprotein A-II Isoform As A Biomarker For Prostate Cancer |
| 10/09/2008 | US20080248499 Using cross sectional shaped flow channel to isolate/recover cancer cell from bodily fluid |
| 10/09/2008 | US20080248498 Methods and compositions to diagnose trichomonas infection |
| 10/09/2008 | US20080248497 Multimeric immunoglobulin specific for rickettsia polypeptides; veterinary medicine; diagnosing flea borne infection in dogs |
| 10/09/2008 | US20080248496 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 10/09/2008 | US20080248495 Protease Activated Receptor (PAR) activating peptide for use as screening tool in identifying modulators for treatment of thrombosis |
| 10/09/2008 | US20080248494 Diagnosing menopause via follicle stimulating hormone specfic immunoglobulins |
| 10/09/2008 | US20080248493 Acridinium phenyl esters useful in the analysis of biological samples |
| 10/09/2008 | US20080248492 Membrane Based Assays |
| 10/09/2008 | US20080248491 Biomarker fragments for the detection of human bnp |
| 10/09/2008 | US20080248490 Tyrosine phosphorylated leukemia-related signaling protein specific immunoglobulin for use as evaluative tools in diagnosing/predicting cell proliferative disorders; protein phosphorylation and cancer detection |
| 10/09/2008 | US20080248489 Methods and compositions for directed microwave chemistry |
| 10/09/2008 | US20080248488 Platelet surface membrane glycoproteins and/or p-selectin patterning for use as evaluative tool in predicting heart associated disorders |
| 10/09/2008 | US20080248487 Modulation of protein functionalities |
| 10/09/2008 | US20080248486 Type Pept1 Protein Assay |
| 10/09/2008 | US20080248485 Radiolabeled 3-[3- (Benzoyl-Amido) Benzyloxy] Aspartic Acid Derivative and Method of Producing the Same |
| 10/09/2008 | US20080248483 Methods of identifying therapeutic compounds in a genetically defined setting |
| 10/09/2008 | US20080248482 Biomarkers for toxic algae |
| 10/09/2008 | US20080248479 Methods for Isolating and Characterizing Endogenous mRNA-Protein (mRNP) Complexes |
| 10/09/2008 | US20080248478 Molecular histological analysis of multicellular samples |